The company is working with the U.S. regulator to move forward with an updated application, adding a decision is expected in ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Sub-Tenon injection of mitomycin C may be an alternative ...
PLYMOUTH MEETING, Pa., June 26, 2021 /PRNewswire/ — Braeburn announces that the New Drug Application (NDA) for BRIXADI (buprenorphine) extended-release weekly and monthly injection for subcutaneous ...
Please provide your email address to receive an email when new articles are posted on . Amphastar Pharmaceuticals received FDA approval of its abbreviated new drug application for ganirelix acetate ...
TARRYTOWN, N.Y., April 18, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (REGN) today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter (CRL) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results